Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Recombinant gallid herpesvirus 3 (MDV serotype 2) vectors expressing antigens of avian pathogens and uses thereof

Recombinant gallid herpesvirus 3 (MDV serotype 2) vectors expressing antigens of avian pathogens and uses thereof

US Patent 9770502 · Granted Sep 26, 2017

Estimated economic value: $121,816,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Recombinant HVT vectors expressing multiple antigens of avian pathogens and uses2025
Recombinant HVT vectors expressing multiple antigens of avian pathogens and uses2025
Recombinant HVT vectors expressing multiple antigens of avian pathogens and uses2025
Recombinant HVT vectors expressing multiple antigens of avian pathogens and uses2025
Modified Marek's disease virus, and vaccines made therefrom2025
Modified Marek's disease virus, and vaccines made therefrom2025
Modified Marek's disease virus, and vaccines made therefrom2025
Modified Marek's disease virus, and vaccines made therefrom2022
Modified Marek's disease virus, and vaccines made therefrom2022
Modified Marek's disease virus, and vaccines made therefrom2022
Recombinant HVT vectors expressing multiple antigens of avian pathogens and uses2022
Recombinant HVT vectors expressing multiple antigens of avian pathogens and uses2022